
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
0:00
Stream Type LIVE
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Alzheimer's Disease Research Highlights
By
Banner Alzheimer's Institute
FEATURING
Pierre Tariot
By
Banner Alzheimer's Institute
FEATURING
Pierre Tariot
747 views
July 10, 2024
Disclaimer: On July 2, 2024 the FDA approved Kisunla (donanemab-azbt) injection for the treatment of ...
read more ↘ Alzheimer’s disease. Treatment should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was studied in the clinical trials.
↖ read less
read more ↘ Alzheimer’s disease. Treatment should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was studied in the clinical trials.
↖ read less
Comments 0
Login to view comments.
Click here to Login